Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Joel Waksman"'
Autor:
Tadeusz Robak, Robin Eisch, Jürgen C. Becker, Youn H. Kim, Susan E. Bates, Madeleine Duvic, Adam Lerner, Joel Waksman, Richard Piekarz, Sean Whittaker, Alexey Samtsov, William McCulloch
Cutaneous T-cell lymphomas (CTCL) are a group of non-Hodgkin lymphomas that typically present in the skin but can progress to systemic involvement. The optimal treatment for patients who relapse from or are refractory to systemic chemotherapy remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3987365ae405602a6f2c7c87fb57e0
https://www.ncbi.nlm.nih.gov/pubmed/28853310
https://www.ncbi.nlm.nih.gov/pubmed/28853310
Autor:
Ronald Sobecks, Jerome B. Zeldis, Matt Kalaycio, Janice Reed, Aleksandr Lazaryan, Steven Andresen, Rachid Baz, Kimberly Hamilton, Beth Faiman, Mary Ann Karam, Joel Waksman, Gordan Srkalovic, Frederic J. Reu, John Sweetenham, Robert M. Dean, Robert Knight, Becky Habecker, Kellie Bruening, Mohamad A. Hussein
Publikováno v:
American Journal of Hematology. 89:349-354
A previous interim report of MM-011, the first study that combined lenalidomide with anthracycline-based chemotherapy followed by lenalidomide maintenance for relapsed and/or refractory multiple myeloma (RRMM), showed promising safety and activity. W
Autor:
Andrew R. Blight, Kathleen M. Zackowski, Ali Fatemi, Adrian L. Rabinowicz, Eileen Fowler, Angeli Mayadev, Gustavo Suarez, Francois Bethoux, Joel Waksman, Enrique Carrazana, Christina Marciniak
Publikováno v:
Clinical therapeutics. 39(2)
Purpose The goal of this study was to evaluate the safety and tolerability of dalfampridine extended release (D-ER) in a pilot study of adults with cerebral palsy (CP) and limited ambulatory ability, and to explore drug effects on sensorimotor functi
Publikováno v:
Clinical lymphoma, myelomaleukemia. 16(11)
Background Tumor stage and folliculotropic mycosis fungoides are uncommon subtypes of cutaneous T-cell lymphoma (CTCL) with an aggressive disease course. Romidepsin is a histone deacetylase inhibitor approved by the US Food and Drug Administration fo
Publikováno v:
Clinical Therapeutics. 29:1057-1070
Background: Although nonprescription oral phenylephrine 10 mg has been judged “generally recognized as safe and effective” by the US Food and Drug Administration (FDA), its efficacy as a nasal decongestant has been questioned. Objective: This stu
Autor:
Youn H. Kim, Adam Lerner, Alain H. Rook, Tadeusz Robak, Sunil Reddy, Joel Waksman, Ellen J. Kim, Jürgen C. Becker, Alexey Samtsov, William McCulloch, Madeleine Duvic, Sean Whittaker
Publikováno v:
Leukemia & Lymphoma
Cutaneous T-cell lymphoma (CTCL) is a rare heterogeneous group of non-Hodgkin lymphomas that arises in the skin but can progress to systemic disease (lymph nodes, blood, viscera). Historically, in clinical trials of CTCL there has been little consist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4137deae494a0c83255e610f1ab8bf9e
https://www.ncbi.nlm.nih.gov/pubmed/25791237
https://www.ncbi.nlm.nih.gov/pubmed/25791237
Autor:
Tailiang Xie, Joel Waksman
Publikováno v:
Statistics in Medicine. 22:2835-2846
Many clinical trials involve the collection of data on the time to occurrence of the same type of multiple events within sample units, in which ordering of events is arbitrary and times are usually correlated. To design a clinical trial with this typ
Autor:
Stephen A. Cooper, Elliot V. Hersh, Joel Waksman, Geraldine Doyle, Douglas Hong, David Wedell, Lawrence M. Levin, Stacey A. Secreto
Publikováno v:
Clinical Therapeutics. 22:1306-1318
Background: Ibuprofen liquigel is a solubilized potassium ibuprofen 200-mg gelatin capsule formulation that was approved for over-the-counter use in 1995. Objective: This study compared the analgesic efficacy and tolerability of ibuprofen liquigel 20
Autor:
Joel Waksman, Lisa M. Ford
Publikováno v:
Pediatrics. 105:1372-1375
Autor:
Joel Waksman, Christine Kollar
Publikováno v:
Statistics in Medicine. 28:534-536